Skip to content

Evaluation of Metabolic Activity of Liver Metastases by FDG-PET Scanning

Exploratory Study on FDG-PET Scanning in Evaluating the Metabolic Activity of Liver Metastases Before and After Resection of the Primary Tumor in Patients With a Colorectal Malignancy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00184782
Enrollment
30
Registered
2005-09-16
Start date
2003-09-30
Completion date
2008-12-31
Last updated
2007-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Neoplasms

Keywords

colorectal cancer, liver metastases, metabolic activity

Brief summary

The purpose of this study is to evaluate the effect of primary tumor resection on the metabolic activity of metastases in patients with a colorectal primary tumor and synchronous liver metastases by positron emission tomography (PET) with 2-deoxy-2-fluoro\[18F\]-D-glucose (FDG-PET) scanning.

Detailed description

The goal of this study is to evaluate the activity of liver metastases before and after resection of the primary tumor. Non-invasive assessment of tumor metabolism is possible in vivo by means of positron emission tomography (PET)-scanning. Therefore, FDG-PET scan offers a suitable approach to determine the influence of removal of a primary colorectal tumor on metabolic activity of the liver metastases. The FDG uptake in the liver metastases is quantified by calculating standardised uptake values (SUVs).

Interventions

PROCEDUREFDG-PET

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Colorectal cancer and synchronous liver metastases

Exclusion criteria

* Pregnancy

Design outcomes

Primary

MeasureTime frame
Increase in metabolic activity of liver metastases after resection of the primary tumor compared to the activity of metastases in patients without primary tumor resection

Countries

Netherlands

Contacts

Primary ContactCharlotte Peeters, MD
C.Peeters@chir.umcn.nl+31-24-3611111
Backup ContactTheo Ruers, PhD
T.Ruers@chir.umcn.nl+31-24-3611111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026